Alnylam Pharmaceuticals earnings

Next report

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Oct 30, 2025, during the session.

Who else reports that week: the earnings calendar.

Last report: Jul 30, 2026, 12:06 ET (during the session). The filing on SEC EDGAR ↗

Across the last 4 reports we hold closes for, the first close moved a median 5.46% either way. Up 1 of 4.

Moves are only shown for reports where we hold closing prices.

1. Jul 30, 202612:06 ET · during the session8-K ↗−28.31%1DRevenue $1.29B+66.9% y/yEPS $1.21quarter to Jun 30, 2026
2. Apr 30, 202612:04 ET · during the session8-K ↗+2.76%1D
3. Feb 12, 202613:05 ET · during the session8-K ↗−4.28%1DRevenue $1.10B+84.9% y/yquarter to Dec 31, 2025
4. Oct 30, 202512:06 ET · during the session8-K ↗−6.65%1DRevenue $1.25B+149.3% y/yEPS $1.84quarter to Sep 30, 2025
5. Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
6. Jul 31, 202512:05 ET · during the session8-K ↗Revenue $773.7M+17.3% y/yEPS −$0.55quarter to Jun 30, 2025
7. Jan 13, 202512:31 ET · during the session8-K ↗Revenue $593.2M+34.9% y/yquarter to Dec 31, 2024
8. Feb 15, 202413:10 ET · during the session8-K ↗Revenue $439.7M+31.2% y/yquarter to Dec 31, 2023
9. Nov 2, 202312:10 ET · during the session8-K ↗Revenue $750.5M+184.0% y/yEPS $1.15quarter to Sep 30, 2023
10. Aug 3, 202312:10 ET · during the session8-K ↗Revenue $318.8M+41.8% y/yEPS −$2.21quarter to Jun 30, 2023
11. May 4, 202312:10 ET · during the session8-K ↗Revenue $319.3M+49.7% y/yEPS −$1.40quarter to Mar 31, 2023
12. Feb 23, 202313:10 ET · during the session8-K ↗Revenue $335.0Mquarter to Dec 31, 2022
13. Jan 9, 202312:00 ET · during the session8-K ↗Revenue $335.0Mquarter to Dec 31, 2022
14. Oct 27, 202212:10 ET · during the session8-K ↗Revenue $264.3MEPS −$3.32quarter to Sep 30, 2022
15. Jul 28, 202212:10 ET · during the session8-K ↗Revenue $224.8M+1.9% y/yEPS −$2.29quarter to Jun 30, 2022

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. 2 other Item 2.02 filings, filed weeks ahead of a report (a delivery or preliminary update), are not counted as reports. Prior-session closes only; not a forecast, not advice.